FDA panel rejects MDMA-based treatment for PTSD ...Middle East

The Hill - News
FDA panel rejects MDMA-based treatment for PTSD
A potential treatment for post-traumatic stress disorder using the psychedelic MDMA was overwhelmingly rejected by a panel of federal regulators on Tuesday, marking what could be a major setback for the use of psychedelics in the treatment of mental illness. The Food and Drug Administration (FDA) panel voted 10-1 against endorsing the safety of MDMA in treating PTSD, and 9-2 against its efficacy. The group cited flawed studies, unclear data and potential for damaging side effects. The FDA is not required to follow the panel’s recommendation in whether to approve the use of MDMA, though the thorough criticism could be used as a rationale to reject the treatment. “It seems like the

Hence then, the article about fda panel rejects mdma based treatment for ptsd was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA panel rejects MDMA-based treatment for PTSD )

Apple Storegoogle play

Last updated :

Also on site :



Latest News